This Article Full Text (PDF) Erratum (v42,p2102) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCormick, D. L. Articles by Moon, R. C. Search for Related Content PubMed PubMed Citation Articles by McCormick, D. L. Articles by Moon, R. C.

Enhanced Inhibition of Mammary Carcinogenesis by Combined Treatment with N-(4-Hydroxyphenyl)retinamide and Ovariectomy¹

Laboratory of Pathophysiology, Life Sciences Division, IIT Research Institute, Chicago, Illinois 60616

Bilateral ovariectomy and dietary administration of the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are both effective inhibitors of chemical carcinogenesis in the rat mammary gland. The present study was designed to determine whether an enhanced inhibitory effect is obtained with combined ovariectomy and 4-HPR administration, compared to either treatment alone. In separate experiments, 50-day-old virgin female Sprague-Dawley rats received either a single i.v. injection of 50 mg N-methyl-N-nitrosourea per kg body weight or a single intragastric dose of 20 mg 7,12-dimethylbenz(a)anthracene. The experimental design was the same in both the N-methyl-N-nitrosourea and 7,12-dimethylbenz(a)anthracene experiments: Group 1, 25 intact rats, placebo diet; Group 2, 25 intact rats, supplement of 782 mg 4-HPR per kg diet; Group 3, 50 ovariectomized rats, placebo diet; Group 4, 50 ovariectomized rats, supplement of 782 mg 4-HPR per kg diet. Feeding of the 4-HPR supplement was begun 7 days after carcinogen administration; ovariectomy was performed 7 days post-7,12-dimethylbenz(a)anthracene or 14 days post-N-methyl-N-nitrosourea. In both experiments, combined ovariectomy plus 4-HPR was significantly more active in suppressing mammary cancer induction than was either manipulation alone. 4-HPR was a more effective inhibitor of carcinogenesis in ovariectomized rats than in intact animals. These data indicate that 4-HPR is highly effective in inhibiting ovarian hormone-independent cancers and suggest that retinoid inhibition of mammary carcinogenesis does not involve an influence on ovarian hormone action.

¹ Supported in part by Contracts NO1-CP-23292 and NO1-CB-74207 from the National Cancer Institute. Presented in part at the 72nd Annual Meeting of the American Association for Cancer Research, Inc., Washington, D. C., April 27 to 30, 1981 (8).

² To whom requests for reprints should be addressed.

Received 6/16/81. Accepted 11/ 5/81.

This article has been cited by other articles:

				M. G. Manjanatha, S. Shelton, M. E. Bishop, L. E. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue(R) transgenic rats. Carcinogenesis, December 1, 2006; 27(12): 2555 - 2564. [Abstract] [Full Text] [PDF]

				M. Manjanatha, S. Shelton, M. Bishop, L. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats Carcinogenesis, October 1, 2006; 27(10): 1970 - 1979. [Abstract] [Full Text] [PDF]

				Y. Wang, R. Yao, A. Maciag, C. J. Grubbs, R. A. Lubet, and M. You Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide. Mol. Cancer Ther., April 1, 2006; 5(4): 1060 - 1072. [Abstract] [Full Text] [PDF]

				A. Guerrieri-Gonzaga, C. Robertson, B. Bonanni, D. Serrano, M. Cazzaniga, S. Mora, M. Gulisano, H. Johansson, F. Formelli, M. Intra, et al. Preliminary Results on Safety and Activity of a Randomized, Double-Blind, 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in Premenopausal Women J. Clin. Oncol., January 1, 2006; 24(1): 129 - 135. [Abstract] [Full Text] [PDF]

				L. A. Hansen, C. C. Sigman, F. Andreola, S. A. Ross, G. J. Kelloff, and L. M. De Luca Retinoids in chemoprevention and differentiation therapy Carcinogenesis, July 1, 2000; 21(7): 1271 - 1279. [Abstract] [Full Text] [PDF]

				C. Rodriguez-Burford, R. A. Lubet, I. Eto, M. M. Juliana, G. J. Kelloff, C. J. Grubbs, and V. E. Steele Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model Carcinogenesis, January 1, 1999; 20(1): 71 - 76. [Abstract] [Full Text] [PDF]